<DOC>
	<DOCNO>NCT02337569</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety NPC-02 patient Zinc Deficiency .</brief_summary>
	<brief_title>A Randomized , Double-Blind , Placebo Controlled Study NPC-02 Patients With Zinc Deficiency</brief_title>
	<detailed_description />
	<criteria>The serum zinc concentration normal level registration 1 . Heavy hepatitis 2 . Malignant tumor 3 . Severe heart disease , hematological disorder , kidney disease pancreatic disease , etc . 4 . The serum albumin 2.8 g/dL 5 . Patient allergy hyperesthesia zinc contain medicine manufacturing ( include supplement ) 6 . Patient take medicine include zinc ( include supplement ) within 12 week registration 7 . Pregnant , suspect pregnant , lactating , patient wish child 8 . Patient participate clinical trial within 12 week registration 9 . Unsuitable target clinical trial judge doctor</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>